Henry Schein, Inc. (NASDAQ:HSIC) released its quarterly earnings data on Tuesday. The company reported $1.75 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.73 by $0.02, RTT News reports. Henry Schein had a return on equity of 19.74% and a net margin of 4.53%. The company had revenue of $3.06 billion during the quarter, compared to analysts’ expectations of $3.05 billion. During the same period last year, the firm posted $1.64 earnings per share. The business’s revenue was up 6.4% on a year-over-year basis. Henry Schein updated its FY17 guidance to $7.17-7.30 EPS.

Shares of Henry Schein (NASDAQ:HSIC) opened at 174.02 on Wednesday. Henry Schein has a 12-month low of $146.23 and a 12-month high of $186.99. The firm has a market capitalization of $13.80 billion, a PE ratio of 26.45 and a beta of 1.09. The company’s 50-day moving average price is $183.03 and its 200 day moving average price is $174.57.

ILLEGAL ACTIVITY NOTICE: “Henry Schein, Inc. (HSIC) Posts Earnings Results, Beats Expectations By $0.02 EPS” was published by American Banking News and is the property of of American Banking News. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/08/08/henry-schein-inc-hsic-releases-quarterly-earnings-results-beats-expectations-by-0-01-eps.html.

In other Henry Schein news, EVP Gerald A. Benjamin sold 12,578 shares of the stock in a transaction on Thursday, May 11th. The stock was sold at an average price of $175.10, for a total transaction of $2,202,407.80. Following the sale, the executive vice president now owns 44,061 shares in the company, valued at $7,715,081.10. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 1.27% of the company’s stock.

Several large investors have recently bought and sold shares of HSIC. Eads & Heald Investment Counsel increased its stake in Henry Schein by 0.5% in the second quarter. Eads & Heald Investment Counsel now owns 1,497 shares of the company’s stock valued at $274,000 after buying an additional 8 shares in the last quarter. Girard Partners LTD. increased its stake in Henry Schein by 0.3% in the first quarter. Girard Partners LTD. now owns 3,115 shares of the company’s stock valued at $529,000 after buying an additional 10 shares in the last quarter. Cleararc Capital Inc. increased its stake in Henry Schein by 0.6% in the first quarter. Cleararc Capital Inc. now owns 1,950 shares of the company’s stock valued at $331,000 after buying an additional 11 shares in the last quarter. Intrust Bank NA increased its stake in Henry Schein by 1.1% in the second quarter. Intrust Bank NA now owns 1,219 shares of the company’s stock valued at $223,000 after buying an additional 13 shares in the last quarter. Finally, Penserra Capital Management LLC increased its stake in Henry Schein by 1.0% in the first quarter. Penserra Capital Management LLC now owns 1,518 shares of the company’s stock valued at $258,000 after buying an additional 15 shares in the last quarter. Hedge funds and other institutional investors own 90.87% of the company’s stock.

HSIC has been the subject of a number of recent analyst reports. Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $206.00 price objective for the company in a research report on Friday, June 16th. Northcoast Research raised Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price objective for the company in a research report on Monday. Stifel Nicolaus raised their price objective on Henry Schein from $174.00 to $178.00 and gave the company a “hold” rating in a research report on Wednesday, May 10th. Finally, Craig Hallum initiated coverage on Henry Schein in a research report on Tuesday, April 11th. They issued a “hold” rating for the company. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have assigned a buy rating to the company. Henry Schein has an average rating of “Hold” and an average price target of $185.56.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Earnings History for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.